[Clinical and experimental use of ATP in internal ear diseases]. | Canada Hyperbarics Skip to main content
Clinical Study Acta oto-laryngologica 1977

[Clinical and experimental use of ATP in internal ear diseases].

Jakobi H, Spinar H, Kuhl KD, Lotz P, Haberland EJ — Acta oto-laryngologica, 1977

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers administered intra-arterial ATP infusions, often with glucose and hyaluronidase, to 267 patients with various inner ear disturbances, including sudden deafness, and also conducted animal experiments.

What They Found

Intra-arterial ATP infusions were successful in 267 patients with inner ear disturbances, particularly sudden deafness, showing good clinical results even in later-treated cases. The combination of ATP with hyperbaric oxygen was also successful in patients who previously showed no improvement. However, animal experiments using guinea pigs to model sudden deafness were unsuccessful due to differing patterns.

What This Means for Canadian Patients

This 1977 study suggests a potential, albeit unspecific, benefit of intra-arterial ATP infusions for inner ear disturbances like sudden deafness. However, given the age of the study and the specialized nature of the treatment, Canadian patients should consult current medical guidelines and specialists for evidence-based care.

Canadian Relevance

This study has no direct Canadian connection or specific relevance to the Canadian healthcare system.

Study Limitations

A key limitation is the inability to demonstrate an increase of ATP in cochlear cells after infusions, suggesting an unspecific mechanism for the observed clinical successes.

Was this summary helpful?

Study Details

Study Type Clinical Study
Category Sudden Hearing Loss
Source Pubmed
PubMed ID 320814
Year Published 1977
Journal Acta oto-laryngologica
MeSH Terms Adenosine Triphosphate; Animals; Clinical Trials as Topic; Deafness; Drug Combinations; Drug Evaluation; Drug Evaluation, Preclinical; Glucose; Guinea Pigs; Humans; Hyaluronoglucosaminidase; Hyperbaric Oxygenation; Hypoxia; Injections, Intra-Arterial; Labyrinth Diseases

Cite This Study

Share

Find a Canadian Clinic Treating Sudden Hearing Loss

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.